SU755199A3 - Method of preparing xanthine derivatives or their salts - Google Patents

Method of preparing xanthine derivatives or their salts

Info

Publication number
SU755199A3
SU755199A3 SU782675299A SU2675299A SU755199A3 SU 755199 A3 SU755199 A3 SU 755199A3 SU 782675299 A SU782675299 A SU 782675299A SU 2675299 A SU2675299 A SU 2675299A SU 755199 A3 SU755199 A3 SU 755199A3
Authority
SU
USSR - Soviet Union
Prior art keywords
salts
xanthine derivatives
preparing xanthine
preparing
derivatives
Prior art date
Application number
SU782675299A
Other languages
English (en)
Inventor
Sten Gakan Aksel Ma Bergstrand
Per Gunnar Kellin
Karl Geran August Persson
Lars Magnus Zerenbi
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Application granted granted Critical
Publication of SU755199A3 publication Critical patent/SU755199A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SU782675299A 1977-10-14 1978-10-13 Method of preparing xanthine derivatives or their salts SU755199A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7711581A SE416810C (sv) 1977-10-14 1977-10-14 Forfarande for framstellning av xantinderivat med antiallergisk aktivitet

Publications (1)

Publication Number Publication Date
SU755199A3 true SU755199A3 (en) 1980-08-07

Family

ID=20332576

Family Applications (1)

Application Number Title Priority Date Filing Date
SU782675299A SU755199A3 (en) 1977-10-14 1978-10-13 Method of preparing xanthine derivatives or their salts

Country Status (21)

Country Link
US (1) US4233303A (ru)
EP (1) EP0001735B1 (ru)
JP (1) JPS5479296A (ru)
AT (1) AT363491B (ru)
AU (1) AU521585B2 (ru)
CA (1) CA1109470A (ru)
CS (1) CS208756B2 (ru)
DD (1) DD139855A5 (ru)
DE (1) DE2862017D1 (ru)
DK (1) DK148260C (ru)
FI (1) FI66383C (ru)
HK (1) HK6385A (ru)
HU (1) HU180219B (ru)
IE (1) IE47884B1 (ru)
IT (1) IT1109208B (ru)
NO (1) NO147562C (ru)
NZ (1) NZ188566A (ru)
SE (1) SE416810C (ru)
SG (1) SG85584G (ru)
SU (1) SU755199A3 (ru)
ZA (1) ZA785335B (ru)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
SE8002910L (sv) * 1980-04-18 1981-10-19 Draco Ab 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar
US4755517A (en) * 1986-07-31 1988-07-05 Warner-Lambert Company Derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US5298508A (en) * 1988-07-19 1994-03-29 The United States Of America As Represented By The Department Of Health And Human Services Irreversible inhibitors of adenosine receptors
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
IT1229195B (it) * 1989-03-10 1991-07-25 Poli Ind Chimica Spa Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
GB8929208D0 (en) * 1989-12-27 1990-02-28 Almirall Lab New xanthine derivatives
US5047534A (en) * 1990-03-26 1991-09-10 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
US5342841A (en) * 1992-03-12 1994-08-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
US5366977A (en) * 1992-09-29 1994-11-22 The United States Of America, As Represented By The Department Of Health And Human Services Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners
US5395836A (en) * 1993-04-07 1995-03-07 Kyowa Hakko Kogyo Co., Ltd. 8-tricycloalkyl xanthine derivatives
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof
EP0799040B1 (en) * 1994-12-13 2003-08-20 Euroceltique S.A. Trisubstituted thioxanthines
WO1996018399A1 (en) * 1994-12-13 1996-06-20 Euro-Celtique, S.A. Aryl thioxanthines
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
WO2004096228A1 (en) 2003-04-25 2004-11-11 Novacardia, Inc. Method of improved diuresis in individuals with impaired renal function
CN101094671A (zh) * 2004-04-16 2007-12-26 美国诺华卡迪亚公司 包含腺苷a1受体拮抗剂和醛固酮抑制剂的组合疗法
US20070049757A1 (en) * 2005-08-26 2007-03-01 Rieger Jayson M Methods for the synthesis of substituted amino uracils

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen
US3900474A (en) * 1973-05-14 1975-08-19 Kendall & Co Trifluoroalkyl, fluorobenzyl, pentafluorobenzyl, fluorobenzenesulfonyl, and pentafluorobenzenesulfonyl theophyllines
US4061753A (en) * 1976-02-06 1977-12-06 Interx Research Corporation Treating psoriasis with transient pro-drug forms of xanthine derivatives
US4120947A (en) * 1976-03-31 1978-10-17 Cooper Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
CA1077932A (en) 1976-03-31 1980-05-20 Berlex Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases

Also Published As

Publication number Publication date
FI783126A (fi) 1979-04-15
DD139855A5 (de) 1980-01-23
FI66383B (fi) 1984-06-29
DK148260C (da) 1986-02-10
HK6385A (en) 1985-02-01
US4233303A (en) 1980-11-11
JPS5479296A (en) 1979-06-25
SE416810B (sv) 1981-02-09
IT7851499A0 (it) 1978-10-13
EP0001735B1 (en) 1982-09-01
DK453778A (da) 1979-04-15
EP0001735A1 (en) 1979-05-02
IT1109208B (it) 1985-12-16
NZ188566A (en) 1984-07-06
SE7711581L (sv) 1979-04-15
ATA714478A (de) 1980-09-15
SG85584G (en) 1985-06-07
ZA785335B (en) 1979-09-26
AT363491B (de) 1981-08-10
CS208756B2 (en) 1981-09-15
CA1109470A (en) 1981-09-22
HU180219B (en) 1983-02-28
NO147562B (no) 1983-01-24
DK148260B (da) 1985-05-20
AU521585B2 (en) 1982-04-22
IE47884B1 (en) 1984-07-11
NO147562C (no) 1983-05-18
IE782041L (en) 1979-04-14
SE416810C (sv) 1982-07-19
NO783471L (no) 1979-04-18
AU4036578A (en) 1980-04-17
FI66383C (fi) 1984-10-10
DE2862017D1 (en) 1982-10-28

Similar Documents

Publication Publication Date Title
SU755199A3 (en) Method of preparing xanthine derivatives or their salts
GB2056455B (en) Method of preparing purine derivatives
SU686616A1 (en) Method of producing derivatives of 3-fluro-6-piperazyl-morphanthridine or their salts
GR65312B (en) Method for the preparation of thiazolidinodiones derivatives
SU725555A3 (en) Method of preparing 2-hydrazonopropionic acid derivatives or their salts
SU755193A3 (en) Method of preparing n-phenylalanine derivatives or their salts
BG30472A1 (en) Method for obtaining of derivatives of 2- pyridil- , respectively of 2- pyrimidil- aminobensoic acid
GR64891B (en) Method for the preparation of derivatives of dis(nitrado-ureido)-polyles
GR65332B (en) Method for the preparation of new derivatives of fortimicine b
GR64924B (en) Method for the preparation of oxadiazole derivatives
CS194843B2 (en) Method of preparing auranofine
PT67617B (en) Process for preparing of azotizinone derivatives
GR64530B (en) Method for the preparation of new derivatives of fortimicine
BG33952A1 (en) A method of obtaining derivatives of phenoxalkanolamine
SU755203A3 (en) Method of preparing 4-androsten-3-ones or their potassium salts
PT66648B (en) Method of preparing thiazole derivatives
GR64159B (en) Method for the preparation of new pyridilo-piperazines derivatives
DE2860746D1 (en) Process for the preparation of 3-bromomethyl-3-cephem-sulphoxide derivatives
GR65311B (en) Method for the preparation of spectinomicyne derivatives
GR65011B (en) Method for the preparation of derivatives of ebournamenine
GR64795B (en) Method for the preparation of imidazoline derivatives
GR59327B (en) Preparation process of alkaloid derivatives
SU755198A3 (en) Method of preparing tetrahydropyridine derivatives or their salts
GR64460B (en) Novel derivatives of phosphorous salts of hydrazinium
GR65659B (en) Method for preparation of derivatives of cloroulanic acid